NOVEMBER 2, 2016

Myeloma–Time To Push for a Cure With MRD End Points

EDITORIAL BOARD

Steven Vogl, MD

Medical Oncologist,
New York City

The last few years have seen an explosion in tolerable new and active drugs to treat multiple myeloma (MM). A list of some of these drugs is presented in Table 1.¹

Table 1. Effective New Drugs for Myeloma^a

Carfilzomib (Kyprolis, Amgen)

Daratumumab (Darzalex, Janssen)

Elotuzumab (Empliciti, Bristol-Myers Squibb)

Isatuximab (Sanofi) (not approved yet)

Ixazomib (Ninlaro, Millennium)

Panobinostat (Farydak, Novartis)

Pembrolizumab

To read the full story, Log in or Sign up for a Free Account

Vogl, NY